-
1
المؤلفون: Lucia Parlati, Catherine Postic, Marion Régnier, Hervé Guillou
المساهمون: LESUR, Hélène, Impact du métabolisme des acides gras des tissus adipeux et du foie sur l'insulinorésistance - - HepAdialogue2017 - ANR-17-CE14-0015 - AAPG2017 - VALID, Institut Cochin (IC UM3 (UMR 8104 / U1016)), Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université Paris Cité (UPCité), Hôpital Cochin [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Université Catholique de Louvain = Catholic University of Louvain (UCL), ToxAlim (ToxAlim), Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Ecole Nationale Vétérinaire de Toulouse (ENVT), Institut National Polytechnique (Toulouse) (Toulouse INP), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National Polytechnique (Toulouse) (Toulouse INP), Université Fédérale Toulouse Midi-Pyrénées-Ecole d'Ingénieurs de Purpan (INPT - EI Purpan), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), Toxicologie Intégrative & Métabolisme (ToxAlim-TIM), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE)-Université Toulouse III - Paul Sabatier (UT3), Lucia Parlati and Catherine Postic received funding from the French association for the study of the liver (AFEF). Catherine Postic and Herve Guillou received funding from the Agence Nationale de la Recherche (ANR-17-CE14-0015Hepadialogue)., ANR-17-CE14-0015,HepAdialogue,Impact du métabolisme des acides gras des tissus adipeux et du foie sur l'insulinorésistance(2017), Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université de Paris (UP)
المصدر: JHEP Reports
JHEP Reports Innovation in Hepatology
JHEP Reports Innovation in Hepatology, 2021, 3 (6), pp.100346. ⟨10.1016/j.jhepr.2021.100346⟩
JHEP Reports Innovation in Hepatology, Elsevier, 2021, 3 (6), pp.100346. ⟨10.1016/j.jhepr.2021.100346⟩مصطلحات موضوعية: HFD, high-fat diet, SREBP-1c, [SDV]Life Sciences [q-bio], Disease, Review, ACC, acetyl-CoA carboxylase, ASK1, apoptosis signal-regulating kinase 1, Chronic liver disease, Bioinformatics, ChREBP, carbohydrate responsive element–binding protein, PPARα, NEFA, TNF-α, tumour necrosis factor-α, 0302 clinical medicine, Fibrosis, Immunology and Allergy, Medicine, IL-, interleukin, VLDL, very low-density lipoprotein, 0303 health sciences, [SDV.MHEP] Life Sciences [q-bio]/Human health and pathology, NEFA, non-esterified fatty acid, Fatty liver, Gastroenterology, NASH, lipotoxicity, FAS, fatty acid synthase, animal models, 3. Good health, [SDV] Life Sciences [q-bio], PY, persons/years, Lipotoxicity, FXR, Saturated fatty acid, JNK, c-Jun N-terminal kinase, 030211 gastroenterology & hepatology, LXR, CAP, controlled attenuation parameter, HSL, hormone-sensitive lipase, HSC, hepatic stellate cells, GGT, gamma glutamyltransferase, NAFLD, non-alcoholic fatty liver disease, ChREBP, NASH, non-alcoholic steatohepatitis, SFA, saturated fatty acid, TCA, tricarboxylic acid, Phf2, histone demethylase plant homeodomain finger 2, digestive system, 03 medical and health sciences, glucotoxicity, FXR, farnesoid X receptor, NAFLD, FFA, free fatty acid, Internal Medicine, RCT, randomised controlled trial, Liver X receptor, PPARa, 030304 developmental biology, FGF21, fibroblast growth factor-21, MCD, methionine- and choline-deficient, HVPG, hepatic venous pressure gradient, Hepatology, business.industry, PUFAs, polyunsaturated fatty acids, nutritional and metabolic diseases, TLR4, Toll-like receptor 4, SCD1, stearoyl-CoA desaturase-1, medicine.disease, digestive system diseases, PPARα, peroxisome proliferator-activated receptor-α, SREBP-1c, sterol regulatory element–binding protein-1c, Steatosis, LXR, liver X receptor, business, HCC, hepatocellular carcinoma, MUFA, monounsaturated fatty acids, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba31673956635c337dc60791ff712432Test
https://pubmed.ncbi.nlm.nih.gov/34667947Test -
2
المؤلفون: Linda Henry, Zobair M. Younossi
المصدر: JHEP Reports
مصطلحات موضوعية: medicine.medical_specialty, NAFLD, non-alcoholic fatty liver disease, Cirrhosis, STAT3, signal transducer and activator of transcription 3, NASH, non-alcoholic steatohepatitis, Context (language use), Disease, Type 2 diabetes, Review, CVD, cardiovascular disease, Gastroenterology, digestive system, ELF, enhanced liver fibrosis, PDGF, platelet-derived growth factor, Internal medicine, Epidemiology, Internal Medicine, Immunology and Allergy, Medicine, awareness, FIB-4, fibrosis-4, ALD, alcohol-related liver disease, neoplasms, Hepatology, business.industry, cirrhosis, Fatty liver, nutritional and metabolic diseases, non-cirrhosis, medicine.disease, Obesity, VEGF, vascular endothelial growth factor, digestive system diseases, natural history, Hepatocellular carcinoma, surveillance, business, HCC, hepatocellular carcinoma, TNF, tumour necrosis factor-α
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48a4964dc0d86470071e38394d6df7fbTest
https://pubmed.ncbi.nlm.nih.gov/34189448Test -
3
المؤلفون: Anneleen Remmerie, Liesbet Martens, Charlotte L. Scott
المصدر: Frontiers in Endocrinology
FRONTIERS IN ENDOCRINOLOGY
Frontiers in Endocrinology, Vol 11 (2020)مصطلحات موضوعية: 0301 basic medicine, POLARIZATION, Endocrinology, Diabetes and Metabolism, ADIPOCYTE DEATH, Adipose tissue, 030209 endocrinology & metabolism, Inflammation, Context (language use), Disease, Review, Biology, liver, lcsh:Diseases of the endocrine glands. Clinical endocrinology, 03 medical and health sciences, 0302 clinical medicine, Endocrinology, INFLAMMATION, Non-alcoholic Fatty Liver Disease, LOCAL PROLIFERATION, medicine, Medicine and Health Sciences, Macrophage, Animals, Humans, NASH (non-alcoholic steatohepatitis), Obesity, Metabolic Syndrome, lcsh:RC648-665, NONALCOHOLIC STEATOHEPATITIS, HEPATIC RECRUITMENT, Macrophages, Fatty liver, NICHE, Biology and Life Sciences, single-cell, medicine.disease, macrophages, adipose tissue, 030104 developmental biology, Immunology, CELLS, Metabolic syndrome, medicine.symptom, DEPLETION, Inflammation Mediators, heterogeneity, SPI-C, non-alcoholic fatty liver disease (NAFLD)
وصف الملف: text/plain
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03d4176e5893622d3bdbf0e1629d38caTest
https://pubmed.ncbi.nlm.nih.gov/32411096Test -
4
المؤلفون: Giacomo Germani, Chiara Becchetti, Patrizia Burra
المصدر: Burra, Patrizia; Becchetti, Chiara; Germani, Giacomo (2020). NAFLD and liver transplantation: Disease burden, current management and future challenges. JHEP reports, 2(6), p. 100192. Elsevier 10.1016/j.jhepr.2020.100192 <http://dx.doi.org/10.1016/j.jhepr.2020.100192Test>
JHEP Reportsمصطلحات موضوعية: medicine.medical_treatment, Review, Disease, Liver transplantation, DPP-4, dipeptidyl peptidase-4, Solid organ transplantation, GLP1 RAs, glucagon-like peptide-1 receptor agonists, mTORi, mammalian target of rapamycin inhibitors, DM, diabetes mellitus, MAFLD, metabolic dysfunction-associated fatty liver disease, Immunology and Allergy, 610 Medicine & health, Non-alcoholic steatohepatitis, Immunosuppressant, Metabolic complication, Fatty liver, Gastroenterology, Graft survival, Immunosuppression, Hypertension, NAFLD, non-alcoholic fatty liver disease, medicine.medical_specialty, NASH, non-alcoholic steatohepatitis, IRR, incidence rate ratio, Diabetes mellitus, Internal Medicine, medicine, Obesity, CNI, calcineurin inhibitors, Intensive care medicine, Disease burden, UNOS, United Network for Organ Sharing, Hepatology, business.industry, CKD, chronic kidney disease, ELTR, European Liver Transplant Registry, Odds ratio, medicine.disease, HR, hazard ratio, SGLT2, sodium-glucose co-transporter-2, OR, odds ratio, ESLD, end-stage liver disease, New-onset diabetes after transplantation, Patient survival, Steatohepatitis, HCC, hepatocellular carcinoma, business, LT, liver transplant, Non-alcoholic fatty liver disease
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b92b01a96954af5a17961262b54974fTest
-
5
المؤلفون: Jérôme Boursier, Emmanuel Tsochatzis
المساهمون: Centre Hospitalier Universitaire d'Angers (CHU Angers), PRES Université Nantes Angers Le Mans (UNAM)
المصدر: JHEP Reports Innovation in Hepatology
JHEP Reports Innovation in Hepatology, Elsevier, 2021, 3 (2), pp.100219. ⟨10.1016/j.jhepr.2020.100219⟩
JHEP Reportsمصطلحات موضوعية: Cirrhosis, Cost effectiveness, [SDV]Life Sciences [q-bio], NICE, National Institute of Clinical Excellence, Nice, Review, AST, aspartate aminotransferase, Disease, Patient pathway, ELF, enhanced liver fibrosis, 0302 clinical medicine, Immunology and Allergy, Medicine, NFS, NAFLD fibrosis score, ALD, alcohol-related liver disease, ComputingMilieux_MISCELLANEOUS, computer.programming_language, 0303 health sciences, NAS, NAFLD activity score, Case-finding, Fatty liver, Gastroenterology, Awareness, Primary care, TE, transient elastography, 3. Good health, Screening, FIB-4, 030211 gastroenterology & hepatology, Elastography, NAFLD, non-alcoholic fatty liver disease, medicine.medical_specialty, NASH, non-alcoholic steatohepatitis, Liver fibrosis, QALY, quality-adjusted life year, 03 medical and health sciences, ALT, alanine aminotransferase, Type 2 diabetes mellitus, NIT, non-invasive test, Internal Medicine, GP, general practitioner, FIB-4, fibrosis-4, Intensive care medicine, 030304 developmental biology, Hepatology, business.industry, Type 2 Diabetes Mellitus, T2DM, type 2 diabetes mellitus, medicine.disease, Quality-adjusted life year, Cost-effectiveness, Transient elastography, business, computer
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::998a5dc5ae8854bb83716af6e6873dc7Test
https://doi.org/10.1016/j.jhepr.2020.100219Test -
6
المؤلفون: Luca Valenti, Elia Casirati, Cristiana Bianco, Francesco Malvestiti
المصدر: JHEP Reports
JHEP Reports, Vol 3, Iss 3, Pp 100284-(2021)مصطلحات موضوعية: SREBP, sterol response element binding protein, Alcoholic liver disease, LDs, lipid droplets, MBOAT7, membrane bound O-acyltransferase domain-containing 7, AA, arachidonic acid, PPAR, peroxisome proliferator-activated receptor, RC799-869, Disease, Review, Bioinformatics, TNF-α, tumour necrosis factor-α, Liver disease, GPR55, G protein-coupled receptor 55, Immunology and Allergy, IL-, interleukin, HFE, homeostatic iron regulator, genetics, GCKR, glucokinase regulator, PNPLA3, patatin like phospholipase domain containing 3, Fatty liver, Gastroenterology, Diseases of the digestive system. Gastroenterology, FGF19, fibroblast growth factor 19, Lipotoxicity, ASH, alcoholic steatohepatitis, PRS, polygenic risk score, FFAs, free fatty acids, HSC, hepatic stellate cells, alcoholic liver disease, IL32, TAG, triacylglycerol, precision medicine, NASH, non-alcoholic steatohepatitis, interleukin-32, HSD17B13, hydroxysteroid 17-beta dehydrogenase 13, steatohepatitis, DNL, de novo lipogenesis, MBOAT7, ER, endoplasmic reticulum, FLD, fatty liver disease, FXR, farnesoid X receptor, Internal Medicine, medicine, Genetic predisposition, PNPLA3, therapy, LPI, lysophosphatidyl-inositol, Hepatology, business.industry, cirrhosis, PUFAs, polyunsaturated fatty acids, non-alcoholic fatty liver disease, medicine.disease, Mitochondrial amidoxime reducing component 1, MARC1, mitochondrial amidoxime reducing component 1, fatty liver disease, Steatohepatitis, business, HCC, hepatocellular carcinoma, DAG, diacylglycerol
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::208fb7d0b5b574d80e6e97a913828e36Test